● Recruiting

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

Condition: Multiple Sclerosis, Relapsing-Remitting · Sponsor: Wayne State University

PhaseN/A

Planned participants80

Who can joinAll sexes, 18 Years to 60 Years

Healthy volunteersNo

About this study

The investigators intend to examine the effects of ocrelizumab use in African American multiple sclerosis disease course compared to Caucasian disease course utilizing imaging measures with magnetic resonance imaging (MRI) and optical coherence tomography angiography (OCT-A)..

This description comes directly from the study's public registry record.

Talk to the study team

Zahid Latif · 3139660473 · zahidlatif@wayne.edu

Kelly Jia · 313-966-9407 · xjia@med.wayne.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Wayne State University

Detroit, Michigan, United States

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04458688